{"title":"用可注射lenacapavir预防艾滋病毒：世卫组织的建议","authors":"Alison Knopf","doi":"10.1002/cbl.30898","DOIUrl":null,"url":null,"abstract":"<p>The World Health Organization (WHO) released new guidelines in July recommending the use of injectable lenacapavir (LEN) twice a year as an additional pre-exposure prophylaxis (PrEP) option for HIV prevention. The landmark policy could help reshape the global HIV response, according to WHO. The guidelines were issued at the 13th International AIDS Society Conference (IAS 2025) on HIV Science, in Kigali, Rwanda.</p>","PeriodicalId":101223,"journal":{"name":"The Brown University Child and Adolescent Behavior Letter","volume":"41 9","pages":"9-10"},"PeriodicalIF":0.0000,"publicationDate":"2025-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Preventing HIV with injectable lenacapavir: WHO recommendation\",\"authors\":\"Alison Knopf\",\"doi\":\"10.1002/cbl.30898\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>The World Health Organization (WHO) released new guidelines in July recommending the use of injectable lenacapavir (LEN) twice a year as an additional pre-exposure prophylaxis (PrEP) option for HIV prevention. The landmark policy could help reshape the global HIV response, according to WHO. The guidelines were issued at the 13th International AIDS Society Conference (IAS 2025) on HIV Science, in Kigali, Rwanda.</p>\",\"PeriodicalId\":101223,\"journal\":{\"name\":\"The Brown University Child and Adolescent Behavior Letter\",\"volume\":\"41 9\",\"pages\":\"9-10\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-08-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Brown University Child and Adolescent Behavior Letter\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/cbl.30898\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Brown University Child and Adolescent Behavior Letter","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/cbl.30898","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Preventing HIV with injectable lenacapavir: WHO recommendation
The World Health Organization (WHO) released new guidelines in July recommending the use of injectable lenacapavir (LEN) twice a year as an additional pre-exposure prophylaxis (PrEP) option for HIV prevention. The landmark policy could help reshape the global HIV response, according to WHO. The guidelines were issued at the 13th International AIDS Society Conference (IAS 2025) on HIV Science, in Kigali, Rwanda.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
